Caricamento...
Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDB
Since the first approval of a protein kinase inhibitor (PKI) by the Food and Drug Administration (FDA) in 2001, 55 new PKIs have reached the market, and many inhibitors are currently being evaluated in clinical trials. This is a clear indication that protein kinases still represent major drug target...
Salvato in:
| Pubblicato in: | Molecules |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7397241/ https://ncbi.nlm.nih.gov/pubmed/32679723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules25143226 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|